Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Hospitals, clinics, and individual medical practitioners are always vulnerable to suit for malpractice, but their actions alone are not necessarily the cause of patients' problems, either real or perceived. In order to provide health care services, the practitioner will generally need to employ diagnostic equipment, prescribe medications, use surgical equipment or implant medical devices. The products drug and device companies put out are so integral to the medical provider's practice that it's often difficult to determine where the practitioner's services end and the effects of these products begins.
The Public Perception
Recently, and particularly during the past few years, the question of how safe medical products are has come to the forefront of the nation's consciousness. Individuals and consumer groups are demanding corporate responsibility and calling for greater government oversight. Medical providers, too, are seeking greater access to information once held back from public dissemination by manufacturers and the government concerning the health consequences of drugs and devices.
In This Issue
The products that the drug and device industries market impact greatly on the quality of care that health care providers can offer their patients. Health care providers must therefore keep abreast of the latest news about the safety of pharmaceutical products. In this Special Issue, we explore some of the new safeguards that are being proposed and put into place to protect consumers from the unintended side effects of using medications and medical devices. We also look at the controversy surrounding the importation of lower-cost medications from foreign sources, and at one case that highlighted the interplay between medical providers and drug manufacturers in marketing pharmaceutical products.
Hospitals, clinics, and individual medical practitioners are always vulnerable to suit for malpractice, but their actions alone are not necessarily the cause of patients' problems, either real or perceived. In order to provide health care services, the practitioner will generally need to employ diagnostic equipment, prescribe medications, use surgical equipment or implant medical devices. The products drug and device companies put out are so integral to the medical provider's practice that it's often difficult to determine where the practitioner's services end and the effects of these products begins.
The Public Perception
Recently, and particularly during the past few years, the question of how safe medical products are has come to the forefront of the nation's consciousness. Individuals and consumer groups are demanding corporate responsibility and calling for greater government oversight. Medical providers, too, are seeking greater access to information once held back from public dissemination by manufacturers and the government concerning the health consequences of drugs and devices.
In This Issue
The products that the drug and device industries market impact greatly on the quality of care that health care providers can offer their patients. Health care providers must therefore keep abreast of the latest news about the safety of pharmaceutical products. In this Special Issue, we explore some of the new safeguards that are being proposed and put into place to protect consumers from the unintended side effects of using medications and medical devices. We also look at the controversy surrounding the importation of lower-cost medications from foreign sources, and at one case that highlighted the interplay between medical providers and drug manufacturers in marketing pharmaceutical products.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
End of year collections are crucial for law firms because they allow them to maximize their revenue for the year, impacting profitability, partner distributions and bonus calculations by ensuring outstanding invoices are paid before the year closes, which is especially important for meeting financial targets and managing cash flow throughout the firm.
Law firms and companies in the professional services space must recognize that clients are conducting extensive online research before making contact. Prospective buyers are no longer waiting for meetings with partners or business development professionals to understand the firm's offerings. Instead, they are seeking out information on their own, and they want to do it quickly and efficiently.
Through a balanced approach that combines incentives with accountability, firms can navigate the complexities of returning to the office while maintaining productivity and morale.
The paradigm of legal administrative support within law firms has undergone a remarkable transformation over the last decade. But this begs the question: are the changes to administrative support successful, and do law firms feel they are sufficiently prepared to meet future business needs?
Counsel should include in its analysis of a case the taxability of the anticipated and sought after damages as the tax effect could be substantial.